1 Davies MR, "Virulence profiling of Streptococcus dysgalactiae subspecies equisimilis isolated from infected humans reveals 2 distinct genetic lineages that do not segregate with their phenotypes or propensity to cause diseases" 44 : 1442-1454, 2007
2 Schrieber L, "Transmission of Streptococcus dysgalactiae subsp. equisimilis between child and dog in an Aboriginal Australian community" 61 : 145-148, 2014
3 Vandamme P, "Taxonomic study of lancefield streptococcal groups C, G, and L (Streptococcus dysgalactiae) and proposal of S. dysgalactiae subsp. equisimilis subsp. nov" 46 : 774-781, 1996
4 Vandamme, "Streptococcus dysgalactiae subsp. equisimilis"
5 Fernie-King BA, "Streptococcal inhibitor of complement (SIC) inhibits the membrane attack complex by preventing uptake of C567 onto cell membranes" 103 : 390-398, 2001
6 Oppegaard O, "Sequence diversity of sicG among group C and G Streptococcus dysgalactiae subspecies equisimilis isolates associated with human infections in western Norway" 33 : 273-277, 2014
7 Åkesson P, "Protein SIC, a novel extracellular protein of Streptococcus pyogenes interfering with complement function" 271 : 1081-1088, 1996
8 Minami M, "Prevalence of a streptococcal inhibitor of a complement-mediated cell lysis-like gene (sicG) in Streptococcus dysgalactiae subsp. equisimilis" 62 : 884-887, 2011
9 Broyles LN, "Population-based study of invasive disease due to β-hemolytic streptococci of groups other than A and B" 48 : 706-712, 2009
10 McMillan DJ, "Population genetics of Streptococcus dysgalactiae subspecies equisimilis reveals widely dispersed clones and extensive recombination" 5 : e11741-, 2010
1 Davies MR, "Virulence profiling of Streptococcus dysgalactiae subspecies equisimilis isolated from infected humans reveals 2 distinct genetic lineages that do not segregate with their phenotypes or propensity to cause diseases" 44 : 1442-1454, 2007
2 Schrieber L, "Transmission of Streptococcus dysgalactiae subsp. equisimilis between child and dog in an Aboriginal Australian community" 61 : 145-148, 2014
3 Vandamme P, "Taxonomic study of lancefield streptococcal groups C, G, and L (Streptococcus dysgalactiae) and proposal of S. dysgalactiae subsp. equisimilis subsp. nov" 46 : 774-781, 1996
4 Vandamme, "Streptococcus dysgalactiae subsp. equisimilis"
5 Fernie-King BA, "Streptococcal inhibitor of complement (SIC) inhibits the membrane attack complex by preventing uptake of C567 onto cell membranes" 103 : 390-398, 2001
6 Oppegaard O, "Sequence diversity of sicG among group C and G Streptococcus dysgalactiae subspecies equisimilis isolates associated with human infections in western Norway" 33 : 273-277, 2014
7 Åkesson P, "Protein SIC, a novel extracellular protein of Streptococcus pyogenes interfering with complement function" 271 : 1081-1088, 1996
8 Minami M, "Prevalence of a streptococcal inhibitor of a complement-mediated cell lysis-like gene (sicG) in Streptococcus dysgalactiae subsp. equisimilis" 62 : 884-887, 2011
9 Broyles LN, "Population-based study of invasive disease due to β-hemolytic streptococci of groups other than A and B" 48 : 706-712, 2009
10 McMillan DJ, "Population genetics of Streptococcus dysgalactiae subspecies equisimilis reveals widely dispersed clones and extensive recombination" 5 : e11741-, 2010
11 Clinical and Laboratory Standards Institute, "Performance standards for antimicrobial susceptibility testing. Twenty-second Informational supplement, M100-S22"
12 Centers for Disease Control and Prevention, "One Health"
13 Yamaoka S, "Neonatal streptococcal toxic shock syndrome caused by Streptococcus dysgalactiae subsp. equisimilis" 29 : 979-981, 2010
14 Malhotra-Kumar S, "Multiplex PCR for simultaneous detection of macrolide and tetracycline resistance determinants in streptococci" 49 : 4798-4800, 2005
15 Takahashi T, "Invasive infection caused by Streptococcus dysgalactiae subsp. equisimilis: characteristics of strains and clinical features" 17 : 1-10, 2011
16 Cohen-Poradosu R, "Group G streptococcal bacteremia in Jerusalem" 10 : 1455-1460, 2004
17 Fujita T, "Genetic diversity in Streptococcus dysgalactiae subsp. equisimilis isolates from patients with invasive and noninvasive infections in a Japanese university hospital (2014-2015)" 70 : 100-104, 2017
18 Smyth D, "DrsG from Streptococcus dysgalactiae subsp. equisimilis inhibits the antimicrobial peptide LL-37" 82 : 2337-2344, 2014
19 Haenni M, "Diversity and mobility of integrative and conjugative elements in bovine isolates of Streptococcus agalactiae, S. dysgalactiae subsp. dysgalactiae, and S. uberis" 76 : 7957-7965, 2010
20 Lo HH, "Distribution of virulence factors and association with emm polymorphism or isolation site among beta-hemolytic group G Streptococcus dysgalactiae subspecies equisimilis" 123 : 45-52, 2015
21 Bramhachari PV, "Disease burden due to Streptococcus dysgalactiae subsp. equisimilis (group G and C streptococcus) is higher than that due to Streptococcus pyogenes among Mumbai school children" 59 : 220-223, 2010
22 Takahashi T, "Clinical aspects of invasive infections with Streptococcus dysgalactiae ssp. equisimilis in Japan: differences with respect to Streptococcus pyogenes and Streptococcus agalactiae infections" 16 : 1097-1103, 2010
23 Mejia LM, "Characterization of group A Streptococcus strains recovered from Mexican children with pharyngitis by automated DNA sequencing of virulence-related genes: unexpectedly large variation in the gene (sic) encoding a complement-inhibiting protein" 35 : 3220-3224, 1997
24 Sylvetsky N, "Bacteremia due to beta-hemolytic Streptococcus group G: increasing incidence and clinical characteristics of patients" 112 : 622-626, 2002
25 Liao CH, "Bacteremia caused by group G streptococci, Taiwan" 14 : 837-840, 2008
26 Bert F, "Analysis of genetic relationships among strains of groups A, C and G streptococci by random amplified polymorphic DNA analysis" 45 : 278-284, 1996